pharmaphorum December 22, 2021

Patient centricity and patient engagement have been hot topics in pharma for some time – but buzz words do not always translate into concrete action.

However, we have seen a framework of guidelines and recommendations during the last year on everything from increasing diversity to producing lay summaries, start to take shape.

As part of our 2021 in Review series, we look back over some of these developments.

Education and empowerment allow for equal access to care

We started the year talking to Ella Balasa, who was diagnosed with cystic fibrosis when she was 18 months old. She set the scene by saying she owed her life to experimental treatments she was only able to access because of her microbiology...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Patient / Consumer, Pharma, Pharma / Biotech, Provider
Disability as the Next Step in DEI Explored at Annual Meeting
What Causes Preventable Child Deaths?
Opinion: Why PHTI’s Recent Assessment of Digital Diabetes Management Tools is Inadequate
Biden’s Executive Order for Studying Women’s Health: How to Not Squander This Opportunity
Navigating the Future of Health™ in an era of change

Share This Article